Journal of Leukemia
Open Access
ISSN: 2329-6917
ISSN: 2329-6917
Department of Cancer Biology, Karolinska Institutet, Stockholm, Sweden
Opinion Article
Minimal Residual Disease as a Precision Marker for Individualized Leukemia Therapy
Author(s): Julia Weber*
DOI:
10.35248/2329-6917-25.13.452